Retatrutide Report / Comparisons
Comparisons
AOD 9604 peptide vs retatrutide: what the evidence shows
AOD 9604 has weak fat-loss evidence and no approval. Retatrutide cut weight 24.2% in trials but also lacks approval. Here's what's actually legal.
Best peptides for weight loss: where retatrutide actually stands
Retatrutide beat placebo by 22 points in a phase 2 trial, but it's not approved or legally compoundable. Here's what the evidence and the law actually say.
Mazdutide vs retatrutide: what the trial data actually shows
Mazdutide and retatrutide are both unapproved triple/dual agonists in trials. Neither is legally sold in the US. Here's how the data and legal status compare.
Retatrutide peptide vs GLP-1 drugs: how they actually differ
Retatrutide hit 24.2% weight loss in trials vs GLP-1 drugs, but it's not FDA-approved and has no lawful compounding path. Here's the real comparison.
Tesamorelin peptide vs retatrutide: what's actually legal and proven
Tesamorelin is FDA-approved for one narrow use. Retatrutide is not approved at all. Here's the real evidence, dosing data, and legal gap between them.